251 related articles for article (PubMed ID: 15914128)
21. Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol.
Stone S
Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():117-21. PubMed ID: 8260969
[TBL] [Abstract][Full Text] [Related]
22. A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen.
Marr J; Gerlinger C; Kunz M
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):91-5. PubMed ID: 22391750
[TBL] [Abstract][Full Text] [Related]
23. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
24. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
Rubio-lotvin B; Ruiz-moreno JA; Gonzalez-ansorena R
Adv Contracept Deliv Syst; 1992; 8(1-2):75-88. PubMed ID: 12285566
[TBL] [Abstract][Full Text] [Related]
25. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
26. A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.
Jespersen J; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Sidelmann JJ; Skouby SO
Contraception; 2005 Aug; 72(2):98-104. PubMed ID: 16022847
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial.
Guang-Sheng F; Mei-Lu B; Li-Nan C; Xiao-Ming C; Zi-Rong H; Zi-Yan H; Xiao-Ping J; Jian L; Shu-Ying W; Cheng-Liang X; Zheng-Ai X; Tian-Fu Y
Clin Drug Investig; 2010; 30(6):387-96. PubMed ID: 20201608
[TBL] [Abstract][Full Text] [Related]
28. Influence of a new oral contraceptive with drospirenone on lipid metabolism.
Taneepanichskul S; Phupong V
Gynecol Endocrinol; 2007 Jun; 23(6):347-50. PubMed ID: 17616860
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
Vartiainen M; de Gezelle H; Broekmeulen CJ
Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
[TBL] [Abstract][Full Text] [Related]
30. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
[TBL] [Abstract][Full Text] [Related]
31. [Clinical study of two monophase oral contraceptives with desogestrel].
Uchikova E; Milchev N; Markova D; Batashki I; Gŭrova A
Akush Ginekol (Sofiia); 2007; 46(2):18-21. PubMed ID: 17469446
[TBL] [Abstract][Full Text] [Related]
32. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
Milsom I; Lete I; Bjertnaes A; Rokstad K; Lindh I; Gruber CJ; Birkhäuser MH; Aubeny E; Knudsen T; Bastianelli C
Hum Reprod; 2006 Sep; 21(9):2304-11. PubMed ID: 16763008
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms.
Sangthawan M; Taneepanichskul S
Contraception; 2005 Jan; 71(1):1-7. PubMed ID: 15639064
[TBL] [Abstract][Full Text] [Related]
34. Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism.
Guazzelli CA; Barreiros FA; Barbosa R; Torloni MR; Barbieri M
Contraception; 2012 Apr; 85(4):389-93. PubMed ID: 22067754
[TBL] [Abstract][Full Text] [Related]
35. Novel ethinyl estradiol-beta-cyclodextrin clathrate formulation does not influence the relative bioavailability of ethinyl estradiol or coadministered drospirenone.
Blode H; Schürmann R; Benda N
Contraception; 2008 Mar; 77(3):171-6. PubMed ID: 18279686
[TBL] [Abstract][Full Text] [Related]
36. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.
Klipping C; Duijkers I; Trummer D; Marr J
Contraception; 2008 Jul; 78(1):16-25. PubMed ID: 18555813
[TBL] [Abstract][Full Text] [Related]
37. The acceptability of a novel oral contraceptive containing drospirenone and its effect on well-being.
Boschitsch E; Skarabis H; Wuttke W; Heithecker R
Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():34-40. PubMed ID: 11246600
[TBL] [Abstract][Full Text] [Related]
38. Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone + 30 microg ethinylestradiol to healthy lactating women.
Blode H; Foidart JM; Heithecker R
Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):167-71. PubMed ID: 11763981
[TBL] [Abstract][Full Text] [Related]
39. Effects of a monophasic pill containing 20 microg ethinylestradiol and 150 microg desogestrel on lipid metabolism in Thai women.
Jaisamrarn U; Taneepanichskul S; Wongwathanavikromn R; Reinprayoon D
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S429-34. PubMed ID: 12188447
[TBL] [Abstract][Full Text] [Related]
40. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
